8 risultati
CROSS REFERENCE TO RELATED APPLICATIONS
This is a National Stage of Application No. PCT/KR2015/012845 filed Nov. 27, 2015, claiming priority based on Korean Patent Application No. 10-2014-0167876 filed Nov. 27, 2014, the contents of all of which are incorporated herein by reference in their
FIELD OF THE INVENTION
The invention relates to chondroitinase ABC I and uses thereof. In particular, the invention relates to recombinantly produced and/or purified chondroitinase ABC I as well as to modified versions of the enzyme. Also provided are methods of producing and uses for the enzymes,
FIELD OF THE INVENTION
The invention relates to chondroitinase ABC I and uses thereof. In particular, the invention relates to recombinantly produced and/or purified chondroitinase ABC I as well as to modified versions of the enzyme. Also provided are methods of producing and uses for the enzymes,
FIELD OF THE INVENTION
The invention relates to chondroitinase ABC I and uses thereof. In particular, the invention relates to recombinantly produced and/or purified chondroitinase ABC I as well as to modified versions of the enzyme. Also provided are methods of producing and uses for the enzymes,
FIELD OF THE INVENTION
The invention relates to chondroitinase ABC I and uses thereof. In particular, the invention relates to recombinantly produced and/or purified chondroitinase ABC I as well as to modified versions of the enzyme. Also provided are methods of producing and uses for the enzymes,
FIELD OF THE INVENTION
The invention relates to chondroitinase ABC I and uses thereof. In particular, the invention relates to recombinantly produced and/or purified chondroitinase ABC I as well as to modified versions of the enzyme. Also provided are methods of producing and uses for the enzymes,
BACKGROUND OF THE INVENTION
This invention is in the field of drugs, pharmacology, and neurology. It relates to drugs that can protect the nervous and cardiovascular systems against conditions such as ischemia and hypoxia.
Ischemia refers to a condition of inadequate blood supply to an internal
FIELD OF THE INVENTION
The present invention concerns a method of treating neurological conditions with an extract of Nerium species or Thevetia species, or preparations (compositions, formulations) containing them. In particular, the invention concerns a method for treating neurological disease or